Dr. Dhananjay Bendre, MD

Dr. Dhananjay Bendre, MD

Radiation Oncology  ·  
Male  ·  
Age 52
(6)
Save
Dr. Dhananjay Bendre, MD is a radiation oncology specialist in Tallahassee, FL and has been practicing for 23 years. He graduated from University Of Medicine and Dentistry Of New Jersey / Robert Wood Johnson Medical School in 1995 and specializes in radiation oncology.

1775 One Healing Pl

Tallahassee, FL 32308

Contact Information

(850) 431-5255

Insurance Accepted

  • Aetna
  • American Republic
  • AvMed
  • Blue Cross Blue Shield
  • Blue Cross Blue Shield of Illinois
  • Blue Cross Blue Shield of Oklahoma
  • Cigna
  • Cofinity
  • Commercial Insurance Company
  • 8 More

*Please verify this information when scheduling an appointment.

Background Check

No malpractice claims found for Florida
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Bendre's experience treating your condition or procedure

Dr. Bendre's Top Procedures and Conditions

Treatment Frequency
Cancer
normal
normal

Treatment Frequency

Dr. Bendre treats Cancer more than 72% of his peers

Dr. Bendre treats this condition more than 72% of his peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer
Gynecologic Cancer
normal
normal

Treatment Frequency

Dr. Bendre treats Gynecologic Cancer more than 39% of his peers

Dr. Bendre treats this condition more than 39% of his peers

Rating Includes other areas of care:

  • Cervical Cancer
  • Choriocarcinoma
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Glassy Cell Carcinoma
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer
Skin Cancer
normal
normal

Treatment Frequency

Dr. Bendre treats Skin Cancer more than 5% of his peers

Dr. Bendre treats this condition more than 5% of his peers

Rating Includes other areas of care:

  • Basal Cell Carcinoma (BCC)
  • Cutaneous Squamous Cell Carcinoma
  • Epidermoid Carcinoma
  • Facial Skin Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Merkel Cell Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Pigmented Basal Cell Carcinoma
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Superficial Basal Cell Carcinoma

Dr. Bendre's conditions and procedures:

Bladder Cancer
Brain Cancer
Brain Tumor
Breast Cancer
Cancer
Cervical Cancer
Colorectal Cancer
Esophageal Cancer
Gynecologic Cancer
Laryngeal Cancer
Lung Cancer
Lymphoma
Pancreatic Cancer
Pituitary Gland Cancer
Prostate Cancer
Rectal Cancer
Sarcoma
Skin Cancer
Thyroid Cancer
Vulvar Cancer

About Me

Biography

Dr. Dhananjay Bendre, MD is a radiation oncology specialist in Tallahassee, FL and has been practicing for 23 years. He graduated from University Of Medicine and Dentistry Of New Jersey / Robert Wood Johnson Medical School in 1995 and specializes in radiation oncology.

Specialties

  • Radiation Oncology

Board Certifications

Education

St Marys and Integrated Hosps
Fellowship Hospital
Ca Pacific M C Pacific
Residency Hospital
Hackensack University Med Center
Residency Hospital
1995
University Of Medicine and Dentistry Of New Jersey / Robert Wood Johnson Medical School
Medical School
Columbia University / College Of Physicians and Surgeons
1995

Awards

Dr. Bendre's Reviews

Likelihood to recommend Dr. Bendre

4.3

Based on 6 reviews

5 Stars
83.33333333333333%
(5)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
16.666666666666668%
(1)

Leave a review

How likely are you to recommend
Dr. Bendre?
(Select your rating)
Average Wait Time
  • 10 – 15 minutes
Dr. Bendre's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. Dhananjay Bendre, MD
Reply
Had an excellent first visit with Dr Bendre for my husband's possible XRT for small cell lung cancer. He was warm and friendly, very knowledgeable and took a long time showing us the scans and discussing possible treatment plans. Totally engaging!
Was this helpful?
thumbs up icon option1
thumbs down icon option
×Post a ResponseAre you Dr. Dhananjay Bendre, MD?

Leave a review

How was your experience with Dr. Bendre?

Locations

Insurance accepted

Accepted insurance can change. Please double-check when making an appointment.

Aetna
Aetna Test HMO
Choice Plus Test POS II
American Republic
AvMed
Open Access
Blue Cross Blue Shield
Blue Card Test PPO
Blue Cross Blue Shield of Illinois
Blue Cross Blue Shield of Illinois PPO
Blue Cross Blue Shield of Oklahoma
Blue Choice Test
Cigna
Cigna PPO
Great West Healthcare-Cigna PPO
Cofinity
Cofinity PPO
Commercial Insurance Company
Coventry Health Care
Group Plan PPO
Coventry Health Care of Florida
Employer Group Open Access HMO
Golden Rule
HAP Insurance
Health Alliance PPO
Humana
Choice Care PPO
Medicaid
MultiPlan
MultiPlan Test PPO
PHCS Network PPO
UnitedHealthCare
Choice Plus Test POS
Navigate HMO
Navigate POS
Options PPO

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Bendre treats patients.

Learn more